Strainsforpains, Inc. (EBYH)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.61 Million USD | 4.67% |
| 2022 | 2.49 Million USD | 5.35% |
| 2021 | 2.36 Million USD | 5.65% |
| 2020 | 2.24 Million USD | 200.4% |
| 2019 | 746 Thousand USD | -59.8% |
| 2018 | 1.85 Million USD | 0.54% |
| 2017 | 1.84 Million USD | 2.22% |
| 2016 | 1.8 Million USD | 36.87% |
| 2015 | 1.31 Million USD | 0.0% |
| 2013 | 1310.30 USD | 0.0% |
| 2007 | 1.11 Million USD | 47.63% |
| 2006 | 757.92 Thousand USD | -57.52% |
| 2005 | 1.78 Million USD | 6.54% |
| 2004 | 1.67 Million USD | 56.85% |
| 2003 | 1.06 Million USD | 69.56% |
| 2002 | 629.64 Thousand USD | -21.84% |
| 2001 | 805.54 Thousand USD | 63.3% |
| 2000 | 493.28 Thousand USD | 10623.59% |
| 1999 | 4600.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.66 Million USD | 2.04% |
| 2023 FY | 2.61 Million USD | 4.67% |
| 2023 Q2 | 2.55 Million USD | 1.16% |
| 2023 Q4 | 2.61 Million USD | 1.13% |
| 2023 Q3 | 2.58 Million USD | 1.14% |
| 2023 Q1 | 2.52 Million USD | 1.17% |
| 2022 Q3 | 2.46 Million USD | 1.2% |
| 2022 Q4 | 2.49 Million USD | 1.18% |
| 2022 FY | 2.49 Million USD | 5.35% |
| 2022 Q1 | 2.4 Million USD | 1.65% |
| 2022 Q2 | 2.43 Million USD | 1.21% |
| 2021 Q2 | 1.89 Million USD | 0.0% |
| 2021 FY | 2.36 Million USD | 5.65% |
| 2021 Q1 | 1.89 Million USD | -15.45% |
| 2021 Q4 | 2.36 Million USD | 1.68% |
| 2021 Q3 | 2.32 Million USD | 22.89% |
| 2020 Q1 | 1.86 Million USD | 0.54% |
| 2020 Q4 | 2.24 Million USD | 20.11% |
| 2020 FY | 2.24 Million USD | 200.4% |
| 2020 Q3 | 1.86 Million USD | 0.0% |
| 2020 Q2 | 1.86 Million USD | 0.0% |
| 2019 Q2 | 1.85 Million USD | 0.0% |
| 2019 FY | 746 Thousand USD | -59.8% |
| 2019 Q4 | 1.85 Million USD | 0.0% |
| 2019 Q3 | 1.85 Million USD | 0.0% |
| 2019 Q1 | 1.85 Million USD | 0.0% |
| 2018 Q4 | 1.85 Million USD | 0.0% |
| 2018 Q3 | 1.85 Million USD | -0.0% |
| 2018 Q2 | 1.85 Million USD | -0.0% |
| 2018 Q1 | 1.85 Million USD | 0.0% |
| 2018 FY | 1.85 Million USD | 0.54% |
| 2017 FY | 1.84 Million USD | 2.22% |
| 2016 FY | 1.8 Million USD | 36.87% |
| 2015 FY | 1.31 Million USD | 0.0% |
| 2013 FY | 1310.30 USD | 0.0% |
| 2008 Q2 | 1.34 Million USD | 9.95% |
| 2008 Q1 | 1.22 Million USD | 9.53% |
| 2008 Q3 | 691.63 Thousand USD | -48.67% |
| 2007 Q2 | 908.88 Thousand USD | 8.39% |
| 2007 Q3 | 1 Million USD | 10.93% |
| 2007 FY | 1.11 Million USD | 47.63% |
| 2007 Q1 | 838.52 Thousand USD | 10.63% |
| 2007 Q4 | 1.11 Million USD | 10.98% |
| 2006 FY | 757.92 Thousand USD | -57.52% |
| 2006 Q4 | 757.92 Thousand USD | -62.66% |
| 2006 Q2 | 1.94 Million USD | 3.81% |
| 2006 Q1 | 1.87 Million USD | 5.15% |
| 2006 Q3 | 2.02 Million USD | 4.21% |
| 2005 Q1 | 1.76 Million USD | 5.54% |
| 2005 Q3 | 1.73 Million USD | 5.31% |
| 2005 FY | 1.78 Million USD | 6.54% |
| 2005 Q2 | 1.64 Million USD | -7.04% |
| 2005 Q4 | 1.78 Million USD | 3.12% |
| 2004 Q3 | 1.5 Million USD | 16.73% |
| 2004 Q2 | 1.28 Million USD | 9.59% |
| 2004 FY | 1.67 Million USD | 56.85% |
| 2004 Q4 | 1.67 Million USD | 11.41% |
| 2004 Q1 | 1.17 Million USD | 10.05% |
| 2003 Q2 | 798.4 Thousand USD | 13.88% |
| 2003 Q3 | 942.51 Thousand USD | 18.05% |
| 2003 FY | 1.06 Million USD | 69.56% |
| 2003 Q1 | 701.07 Thousand USD | 11.34% |
| 2003 Q4 | 1.06 Million USD | 13.28% |
| 2002 FY | 629.64 Thousand USD | -21.84% |
| 2002 Q2 | 200.32 Thousand USD | 0.0% |
| 2002 Q3 | 246.73 Thousand USD | 23.17% |
| 2002 Q4 | 629.64 Thousand USD | 155.19% |
| 2001 FY | 805.54 Thousand USD | 63.3% |
| 2000 FY | 493.28 Thousand USD | 10623.59% |
| 1999 FY | 4600.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Achiko AG | 6.49 Million USD | 59.831% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.37 Million USD | 68.817% |
| Cannabis Sativa, Inc. | 1.26 Million USD | -106.683% |
| CompuMed, Inc. | 1.34 Million USD | -94.068% |
| CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 99.821% |
| Cogstate Limited | 16.91 Million USD | 84.567% |
| CareView Communications, Inc. | 40.52 Million USD | 93.558% |
| Craneware plc | 215.06 Million USD | 98.786% |
| Caduceus Software Systems Corp. | 5.57 Million USD | 53.169% |
| Certive Solutions Inc. | 10.95 Million USD | 76.172% |
| Drug Free Solution, Inc. | 333.29 Thousand USD | -683.303% |
| DATATRAK International, Inc. | 6.18 Million USD | 57.756% |
| Healixa Inc. | 10.57 Million USD | 75.31% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 138.29 Thousand USD | -1787.874% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 1.02 Million USD | -155.324% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5068.58 USD | -51408.332% |
| iCoreConnect Inc. | 11.24 Million USD | 76.778% |
| IQ-AI Limited | 796.65 Thousand USD | -227.712% |
| Cannabiz Mobile, Inc. | 559.05 Thousand USD | -366.994% |
| Mednow Inc. | 9.46 Million USD | 72.428% |
| Galileo Life Sciences, Inc. | 725.46 Thousand USD | -259.87% |
| MediXall Group, Inc. | 4.53 Million USD | 42.385% |
| Mitesco, Inc. | 14.13 Million USD | 81.529% |
| MobileSmith, Inc. | 6.15 Million USD | 57.582% |
| NantHealth, Inc. | 384.94 Million USD | 99.322% |
| Net Medical Xpress Solutions, Inc. | 1.07 Million USD | -142.184% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 11.33 Million USD | 76.961% |
| Patient Access Solutions, Inc. | 2.44 Million USD | -6.825% |
| Pharma-Bio Serv, Inc. | 3.77 Million USD | 30.846% |
| PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 62.911% |
| Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | -10.354% |
| Renalytix Plc | 15.82 Million USD | 83.503% |
| Revium Recovery Inc. | 144 Thousand USD | -1713.015% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.06 Million USD | 14.757% |
| Vaso Corporation | 48.91 Million USD | 94.663% |
| Vynleads, Inc. | 805.33 Thousand USD | -224.182% |